To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

0.00
0.00
arrow

LOWER/UPPER CIRCUITS

1,232.70
1,848.90
arrow
Ipca Laboratories Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 15.36%, in the last year to ₹9,032.39 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 34.77% in the last year to ₹737.68 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
noteQuarterly Revenue,rose 10.51% YoY to ₹2,272.51 Cr. Its sector's average revenue growth YoY for the quarter was 11.18%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 20.31%
Net profit growth 5Y CAGR : 3.57%
Ipca Laboratories Ltd Top mutual funds holding
arrow
IPCA Laboratories Limited incorporated in the year 1949, is integrated pharmaceutical company manufacturing and marketing various formulations and many API’s covering various therapeutic segments. The products of the company are sold in many countries across the globe. The company has numerous manufacturing units in India manufacturing API’s and formulations for the world market. The company is one of the largest suppliers of these APIs worldwide with manufacturing leadership in many APIs globally. It has various APIs and formulations manufacturing facility across the globe. The company has leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy in India.
personal

Grow your wealth with more research recommendations

+91